Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin

Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin

Acute myeloid leukemia (AML) is a complex hematological malignancy characterized by genetic and clinical heterogeneity and high mortality. Despite the recent introduction of novel pharmaceutical agents in hemato-oncology, few advancements have been made in AML for decades. In the last years, the the...

Full description

Bibliographic Details
Main Authors: Michele Gottardi, Giorgia Simonetti, Alessandra Sperotto, Davide Nappi, Andrea Ghelli Luserna di Rorà, Antonella Padella, Marianna Norata, Maria Benedetta Giannini, Gerardo Musuraca, Francesco Lanza, Claudio Cerchione, Giovanni Martinelli
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
CD33
acute myeloid leukemia
gemtuzumab ozogamicin
biomarkers
Online Access:https://www.mdpi.com/2072-6694/13/18/4566

Internet

https://www.mdpi.com/2072-6694/13/18/4566

Similar Items